Ischemic stroke

Ischemic stroke
Name	Ischemic stroke
Field	Neurology
Symptoms	Sudden weakness, speech difficulty, visual disturbance
Complications	Disability, cognitive impairment, death
Onset	Acute
Duration	Permanent or transient
Causes	Thromboembolism, atherosclerosis, cardioembolism
Risks	Hypertension, atrial fibrillation, diabetes mellitus
Diagnosis	Neuroimaging, clinical scales
Treatment	Thrombolysis, thrombectomy, anticoagulation

Ischemic stroke is an acute neurological condition caused by interruption of cerebral blood flow leading to focal brain ischemia and infarction. It presents with sudden neurological deficits and requires rapid evaluation and treatment to reduce morbidity and mortality. Management spans emergent reperfusion, secondary prevention, rehabilitation, and public health measures.

Signs and symptoms

Patients typically present with abrupt focal deficits such as unilateral weakness, numbness, language disturbance, visual field loss, or ataxia; these may be accompanied by altered level of consciousness or neglect. Common presentations overlap with symptoms seen in reports of John F. Kennedy’s advisors on emergency response and descriptions in accounts of Ronald Reagan’s medical episodes, and stroke descriptions appear in biographies of Winston Churchill and Franklin D. Roosevelt for historical context. Neurological examination uses standardized assessments developed in programs associated with National Institutes of Health and clinical trials funded by National Heart, Lung, and Blood Institute; scales such as the National Institutes of Health Stroke Scale were popularized alongside research at Harvard Medical School and Johns Hopkins Hospital. Some focal syndromes recall vascular territories studied by investigators at Mayo Clinic and Massachusetts General Hospital.

Causes and pathophysiology

The major mechanisms include atherothrombotic occlusion of intracranial or extracranial arteries, cardioembolism from sources such as atrial fibrillation, and small vessel occlusive disease. Pathophysiological cascades were characterized in foundational research at institutions like University of Oxford and University of Cambridge and discussed in symposia hosted by World Health Organization and American Heart Association. Thrombus formation on a ruptured atherosclerotic plaque in the carotid artery or vertebral artery can mirror vascular events described in case series from Cleveland Clinic and analyses by teams at Stanford University School of Medicine. Cardioembolic sources trace to arrhythmias managed in trials by groups at European Society of Cardiology and American College of Cardiology. Ischemia triggers excitotoxicity, oxidative injury, blood–brain barrier disruption, and inflammation—mechanisms explored in laboratories at Max Planck Society and Salk Institute. Lacunar infarcts from small vessel lipohyalinosis were first detailed in cohorts at University College London and referenced in work coordinated by Centers for Disease Control and Prevention.

Diagnosis

Rapid diagnosis relies on clinical assessment and neuroimaging such as noncontrast computed tomography and magnetic resonance imaging, technologies advanced at GE Healthcare and Siemens Healthineers and implemented in stroke networks linked to NewYork–Presbyterian Hospital and Mount Sinai Hospital. Vascular imaging with CT angiography or MR angiography identifies large vessel occlusion amenable to thrombectomy, a capability expanded through trials conducted at Karolinska Institute and University of Toronto. Cardiac evaluation with echocardiography and rhythm monitoring detects cardioembolic sources in studies run by Mayo Clinic and Cleveland Clinic. Laboratory testing and biomarkers were validated in multicenter studies coordinated by National Institutes of Health and guideline committees at American Heart Association.

Treatment and management

Acute reperfusion with intravenous tissue plasminogen activator is guided by protocols endorsed by American Heart Association and implemented in comprehensive stroke centers such as Memorial Hermann Hospital; endovascular thrombectomy for large vessel occlusion is supported by randomized trials from consortia including ESCAPE and MR CLEAN investigators associated with Radboud University Medical Center. Antiplatelet therapy with aspirin and dual antiplatelet strategies were established in trials led by teams at Oxford University and Imperial College London; anticoagulation for atrial fibrillation is recommended following landmark studies by groups at Duke University and Brigham and Women’s Hospital. Secondary management integrates risk factor control promoted by programs at World Health Organization and Centers for Disease Control and Prevention, while rehabilitation draws on multidisciplinary models from Rehabilitation Institute of Chicago and Spaulding Rehabilitation Hospital.

Prevention and prognosis

Primary and secondary prevention include hypertension control, lipid lowering with statins proven in trials by research at University of California, San Francisco and University of Edinburgh, smoking cessation campaigns modeled by Campaign for Tobacco-Free Kids and American Cancer Society, and anticoagulation for atrial fibrillation guided by European Society of Cardiology guidelines. Prognosis varies with infarct size, location, age, and comorbidity; long-term outcomes and disability metrics were characterized in cohort studies like the Framingham Heart Study and analyses by Global Burden of Disease collaborators at Institute for Health Metrics and Evaluation. Stroke registries established at institutions such as Get With The Guidelines and international consortia coordinated by World Stroke Organization inform outcome prediction and health policy.

Epidemiology and risk factors

Ischemic events account for the majority of cerebrovascular accidents worldwide; incidence and prevalence trends have been tracked by World Health Organization, Centers for Disease Control and Prevention, and the Institute for Health Metrics and Evaluation. Major modifiable risk factors include hypertension, diabetes mellitus, hyperlipidemia, smoking, and atrial fibrillation; these risk factors were quantified in landmark studies like the Framingham Heart Study and INTERSTROKE, in collaboration with universities such as Harvard University, University of Cambridge, and University of Melbourne. Demographic disparities and aging population effects are described in reports from United Nations demographic studies and health systems analyses at Organisation for Economic Co-operation and Development.

Category:Stroke